Showing posts with label bogus science. Show all posts
Showing posts with label bogus science. Show all posts
Sunday, July 13, 2014
Friday, April 04, 2014
Great article in Trials, on why regulators should stop withholding trial info from doctors and patients
October 18th, 2012 by Ben Goldacre in bad science, big pharma | 5 Comments »
One thing in Bad Pharma has shocked readers more than anything else: the way that vitally important information about trials is withheld from doctors and patients, not just by drug companies, but also by government bodies such NICE and the European Medicines Agency (the body that approves and regulates medicines for the UK).
Great site BAD SCIENCE http://www.badscience.net/
Saturday, March 08, 2014
Breaking News Genzyme Seprafilm
Attorney General J.B. Van Hollen Announces Settlement with Genzyme Corporation to Resolve Allegations of Off-Label Marketing
March 07, 2014
Email
Print
Free Newsletter
| Targeted News Service |
Attorney General J.B. Van Hollen announced today that Wisconsin has joined with other states and the federal government to settle allegations thatGenzyme Corp. (Genzyme ) marketed and caused false claims to be submitted to federal and state health care programs for use of a "slurry" version of its Seprafilm adhesion barrier. Seprafilm is a thin film intended to reduce adhesions after surgery by forming a bio-resorbable barrier between abdominal tissue and organs. Genzyme is a biotechnology corporation based in Cambridge, Mass. , and was acquired by Sanofi-Aventis SA in April 2011 . As part of the settlement, Wisconsin Medicaid will receive $44,698.27 in restitution and other recoveries. Medicaid is a health insurance program for the needy and disabled jointly funded by the state and federal governments. The agreement resolves allegations that Genzyme sales representatives taught doctors and other staff to cut the Seprafilm sheets into small pieces, add saline and allow the pieces to dissolve until the desired consistency was reached. This mixture was referred to as "slurry." Genzyme sales representatives traded recipes for slurry, and trained each other in how to create it. The slurry was used in laparoscopic surgeries by inserting a catheter filled with the mixture into the body and applying it into the abdominal cavity. Seprafilm isFDA -approved for use in open abdominal surgery but not for minimally invasive surgeries, such as laparoscopic surgery. Allegedly, as a result of this conduct,Genzyme knowingly caused hospitals and other purchasers of Seprafilm to submit false and fraudulent claims to health care programs for uses that were not reimbursable.
TNS 30FurigayJof 140307-4659904 30FurigayJof
| Copyright: | (c) 2014 Targeted News Service |
| Wordcount: | 276 |
Wednesday, February 26, 2014
Abdominal Wall Lift ~ Beware the Abdolift
IHRT blast from the past.....
Beware of the Abdo-lift....
Abdominal wall lift decreases cardiopulmonary changes, does not influence the morbidity and, increases operating time in laparoscopic cholecystectomy. It cannot be recommended routinely
.Gurusamy KS, Samraj K, Davidson BR.Published Online: July 16, 2008.Several physiological parameters related to heart and lung (cardiopulmonary changes) occur during insufflation of abdomen (tummy) with key-hole surgery. While these changes can be tolerated by normal individuals, patients with poor heart or lung function may not tolerate the changes. These changes in physiological parameters related to heart and lung are decreased by using special instruments to lift the front wall of the abdomen so that key-hole surgery can be performed without gas insufflation. In this systematic review of 20 trials including 706 patients (six trials including 156 patients used gas at very low pressures), it is shown that the technique of lifting the front wall of the tummy is associated with increased operating time (8 minutes) without reducing surgical complications. It cannot be recommended as a routine in patients with mild or no systemic disease. So, it cannot be recommended routinely in patients with low anaesthetic risk.
http://summaries.cochrane.org/CD006574/abdominal-wall-lift-decreases-cardiopulmonary-changes-does-not-influence-the-morbidity-and-increases-operating-time-in-laparoscopic-cholecystectomy.-it-cannot-be-recommended-routinely
.Gurusamy KS, Samraj K, Davidson BR.Published Online: July 16, 2008.Several physiological parameters related to heart and lung (cardiopulmonary changes) occur during insufflation of abdomen (tummy) with key-hole surgery. While these changes can be tolerated by normal individuals, patients with poor heart or lung function may not tolerate the changes. These changes in physiological parameters related to heart and lung are decreased by using special instruments to lift the front wall of the abdomen so that key-hole surgery can be performed without gas insufflation. In this systematic review of 20 trials including 706 patients (six trials including 156 patients used gas at very low pressures), it is shown that the technique of lifting the front wall of the tummy is associated with increased operating time (8 minutes) without reducing surgical complications. It cannot be recommended as a routine in patients with mild or no systemic disease. So, it cannot be recommended routinely in patients with low anaesthetic risk.
http://summaries.cochrane.org/CD006574/abdominal-wall-lift-decreases-cardiopulmonary-changes-does-not-influence-the-morbidity-and-increases-operating-time-in-laparoscopic-cholecystectomy.-it-cannot-be-recommended-routinely
Where are Kruschinski's studies? Oh right there aren't any real ones, just vividly imagined ones.
Subscribe to:
Posts (Atom)